Anita Varma and Chuck Larsen, White & Case

6 December 2017Big Pharma

LSPN Europe 2017: PTAB facing criticism over political independence

A lawyer speaking at the Life Sciences Patent Network (LSPN) Europe conference has said the US Patent Trial and Appeal Board (PTAB) has come under fire for not being politically independent.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool